Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 2/20 | 0.46 |
| ▸ | MMP8 | P22894 | 2/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27032370 | 1.00 | RCE1 (0.54) | RCE1HTTLMNATSHRALDH1A1 | |
| SCHEMBL875014 | 1.00 | RCE1 (0.54) | RCE1HTTLMNATSHRALDH1A1 | |
| SCHEMBL9730172 | 1.00 | RCE1 (0.54) | RCE1HTTLMNATSHRALDH1A1 | |
| SCHEMBL15013883 | 1.00 | RCE1 (0.54) | RCE1HTTLMNATSHRALDH1A1 | |
| SCHEMBL31571480 | 0.88 | RCE1 (0.54) | RCE1HTTLMNATSHRALDH1A1 | |
| SCHEMBL29049050 | 0.88 | RCE1 (0.54) | RCE1HTTLMNATSHRALDH1A1 | |
| SCHEMBL17663535 | 0.85 | MAPT (0.53) | RCE1HTTLMNATSHRALDH1A1 | |
| SCHEMBL7155541 | 0.85 | MAPT (0.53) | RCE1HTTLMNATSHRALDH1A1 | |
| SCHEMBL20370148 | 0.84 | RCE1 (0.51) | RCE1HTTLMNATSHRALDH1A1 | |
| SCHEMBL13773424 | 0.84 | RCE1 (0.51) | RCE1HTTLMNATSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-62133460-A | — | — | None | — | — | JP | disclosed |
| CN-119546740-A | Cleaning agent for hard surfaces | 轨迹方案IPCO有限责任公司 | 2025-02-28 | — | — | CN | disclosed |
| US-20240246992-A1 | MACROCYCLIC LRRK2 KINASE INHIBITORS | SERVIER LAB (FR) | 2024-07-25 | — | — | US | disclosed |
| EP-4308570-A1 | MACROCYCLIC LRRK2 KINASE INHIBITORS | Les Laboratoires Servier (FR) | 2024-01-24 | — | — | EP | disclosed |
| CN-117425661-A | Macrocyclic LRRK2 kinase inhibitors | 法国施维雅药厂 | 2024-01-19 | — | — | CN | disclosed |
| WO-2022194976-A1 | MACROCYCLIC LRRK2 KINASE INHIBITORS | LES LABORATOIRES SERVIER (FR) | 2022-09-22 | — | — | WO | disclosed |
| EP-3689881-A1 | MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B | Eisai R&D Management Co., Ltd. (JP) | 2020-08-05 | — | — | EP | disclosed |
| EP-2619186-A1 | PROCESS FOR PREPARING PAN-CDK INHIBITORS OF THE FORMULA (I), AND INTERMEDIATES IN THE PREPARATION | Bayer Pharma Aktiengesellschaft (DE) | 2013-07-31 | — | — | EP | disclosed |
| WO-2012038411-A1 | PROCESS FOR PREPARING PAN-CDK INHIBITORS OF THE FORMULA (I), AND INTERMEDIATES IN THE PREPARATION | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-03-29 | — | — | WO | disclosed |
| CN-102267878-A | Method for preparing 1,3-diaroxy or alkoxy-2-propanol compound | — | 2011-12-07 | — | — | CN | disclosed |
| US-5811383-A | WATER, IONIC SURFACTANT, ORGANIC SOLVENT MIXTURES FOR DEGREASING METAL SURFACE; LOW VISCOSITY, LOW CONDUCTIVITY | THE DOW CHEMICAL COMPANY (US) | 1998-09-22 | — | — | US | disclosed |
| WO-1998004761-A1 | HIGH WATER CONTENT, LOW VISCOSITY, OIL CONTINUOUS MICROEMULSIONS AND EMULSIONS, AND THEIR USE IN CLEANING APPLICATIONS | THE DOW CHEMICAL COMPANY (US) | 1998-02-05 | — | — | WO | disclosed |
| US-5597792-A | High water content, low viscosity, oil continuous microemulsions and emulsions, and their use in cleaning applications | THE DOW CHEMICAL COMPANY (US) | 1997-01-28 | — | — | US | disclosed |
| US-5538662-A | LAUNDRY | DOWBRANDS INC. (US) | 1996-07-23 | — | — | US | disclosed |
| US-5490948-A | MIXTURE OF GELLING AGENT, SURFACTANT, SOLVENT AND MIXTURE | DOWBRANDS INC. (US) | 1996-02-13 | — | — | US | disclosed |
| EP-0692021-A1 | MICROEMULSION AND EMULSION CLEANING COMPOSITIONS | THE DOW CHEMICAL COMPANY (US) | 1996-01-17 | — | — | EP | disclosed |
| EP-0625148-A1 | NOVEL BACCATINE III AND 10-DEACETYL BACCATINE III DERIVATIVES, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | Aventis Pharma S.A. (FR) | 1994-11-23 | — | — | EP | disclosed |
| WO-1994023012-A1 | MICROEMULSION AND EMULSION CLEANING COMPOSITIONS | THE DOW CHEMICAL COMPANY (US) | 1994-10-13 | — | — | WO | disclosed |
| WO-1993016060-A1 | NOVEL BACCATINE III AND 10-DEACETYL BACCATINE III DERIVATIVES, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | RHONE-POULENC RORER S.A. (FR) | 1993-08-19 | — | — | WO | disclosed |
| JP-S62133460-A | DEVELOPING SOLUTION COMPOSITION FOR PHOTOSENSITIVE LITHOGRAPHIC PLATE AND METHOD FOR DEVELOPING IT | KONISHIROKU PHOTO IND CO LTD | 1987-06-16 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240246992-A1 | MACROCYCLIC LRRK2 KINASE INHIBITORS | LRRK2, PARK7, PINK1 | RCE1 1055/4885HTT 884/4885LMNA 2450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.